S. 3822 119th Congress
Break Up Big Medicine Act
- Health
- Sponsor: Sen. Warren, Elizabeth [D-MA]
- Congress.gov ↗
Latest action, Feb 10, 2026: Read twice and referred to the Committee on the Judiciary.
How the House voted
The House hasn't taken a roll call on this bill in the Congresses covered.
1 cosponsor
Sponsored by Sen. Warren, Elizabeth [D-MA] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
0 D · 1 R
Referred to: Senate: Judiciary Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
3 reports
3 reports
CENCORA
MONUMENT ADVOCACY
3 reports
3 reports
CENTER FOR HEALTH AND DEMOCRACY
PORT SIDE STRATEGIES, LLC
3 reports
3 reports
3 reports
3 reports
INDEPENDENT PHARMACY COOPERATIVE
FORBES-TATE
3 reports
3 reports
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
THE GIBSON GROUP, LLC
3 reports
The top 25 of 29 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 3 | $11.3M | Q1 2026 | Q3 2026 | yes | |
| AMERICAN MEDICAL ASSOCIATION | 3 | $17.6M | Q1 2026 | Q3 2026 | yes | |
| CARDINAL HEALTH INC | 3 | $2.2M | Q1 2026 | Q3 2026 | yes | |
| CENCORA | MONUMENT ADVOCACY | 3 | $0 | Q1 2026 | Q3 2026 | yes |
| CENCORA, INC. | 3 | $2.1M | Q1 2026 | Q3 2026 | yes | |
| CENTER FOR HEALTH AND DEMOCRACY | PORT SIDE STRATEGIES, LLC | 3 | $60K | Q1 2026 | Q3 2026 | yes |
| CVS HEALTH (AND SUBSIDIARIES) | 3 | $8.9M | Q1 2026 | Q3 2026 | yes | |
| HIGHMARK INC | 3 | $780K | Q1 2026 | Q3 2026 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | 3 | $130K | Q1 2026 | Q3 2026 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | FORBES-TATE | 3 | $0 | Q1 2026 | Q3 2026 | yes |
| KAISER FOUNDATION HEALTH PLAN INC | 3 | $4.0M | Q1 2026 | Q3 2026 | yes | |
| MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY | 3 | $2.0M | Q1 2026 | Q3 2026 | yes | |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 3 | $960K | Q1 2026 | Q3 2026 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 3 | $9.5M | Q1 2026 | Q3 2026 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | THE GIBSON GROUP, LLC | 3 | $0 | Q1 2026 | Q3 2026 | yes |
| PRIME THERAPEUTICS | 3 | $360K | Q1 2026 | Q3 2026 | yes | |
| THE ORTHOFORUM | CUNEO GILBERT & LADUCA | 3 | $45K | Q1 2026 | Q3 2026 | yes |
| AMERICAN SOCIETY OF ANESTHESIOLOGISTS | 2 | $540K | Q2 2026 | Q3 2026 | yes | |
| HEALTHCARE DISTRIBUTION ALLIANCE | GOVERNMENT COUNSEL, LLC | 2 | $80K | Q2 2026 | Q3 2026 | yes |
| HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 2 | $1.1M | Q2 2026 | Q3 2026 | yes |
| NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2 | $770K | Q2 2026 | Q3 2026 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | 1 | $6.1M | Q1 2026 | Q1 2026 | yes | |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | 1 | $120K | Q3 2026 | Q3 2026 | yes | |
| CHAMBER OF COMMERCE OF THE U.S.A. | 1 | $16.9M | Q2 2026 | Q2 2026 | yes | |
| DR. JOSE M. WILEY | LOGICAL DECORUM CAPITAL STRATEGIES, LLC | 1 | $10K | Q1 2026 | Q1 2026 | — |